arGentis Pharmaceuticals, LLC
No bio yet
This person is not in any teams
This person is not in any offices
arGentis Pharmaceuticals, LLC
arGentis Pharmaceuticals, LLS is a private TN based pharmaceutical company with a mid-stage Orphan Drug treatment (ARG201) for late stage diffuse systemic scleroderma (dcSSc). The company is seeking capital to complete a Pivotal Clinical Trial which will enable obtaining marketing approval in the EU.The Company has a genotype marker (ROT1) thatpredicts patient response to treatment by oral tolerance for treatments like ARG201 for dcSSc.